Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome
Molecular and Cellular Endocrinology · 2024-08 · 589 · 112237
DOI: 10.1016/j.mce.2024.112237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024-08. Verfasst von Soumia Brakta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Reproductive Endocrine, Infertility, & Genetics, Department of Obstetrics & Gynecology, Medical College of Georgia at Augusta University, …. Hauptthemen laut MEDLINE: 46, XX Disorders of Sex Development, Chromosomes, Human, Pair 17, Congenital Abnormalities, Heterozygote. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: NICHD.
Abstract (Originalsprache)
The molecular basis of mullerian aplasia, also known as Mayer-Rokitansky-Kuster Hauser (MRKH) or congenital absence of the uterus and vagina, is largely unknown. We applied a multifaceted genetic approach to studying the pathogenesis of MRKH including exome sequencing of trios and duos, genome sequencing of families, qPCR, RT-PCR, and Sanger sequencing to detect intragenic deletions, insertions, splice variants, single nucleotide variants, and rearrangements in 132 persons with MRKH. We identified two heterozygous variants in ZNHIT3 localized to a commonly involved CNV region at chromosome 17q12 in two different families with MRKH. One is a frameshift, truncating variant that is predicted to interfere with steroid hormone binding of the LxxLL sequence of the C-terminal region. The second variant is a double missense/stopgain variant. Both variants impair protein expression in vitro. In addition, four more probands with MRKH harbored the stopgain variant without the nearby missense variant. In total, 6/132 (4.5%) of patients studied, including five with associated anomalies (type 2 MRKH), had ZNHIT3 variants that impair function in vitro. Our findings implicate ZNHIT3 as an important gene associated with MRKH within the 17q12 CNV region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Reproductive Endocrine, Infertility, & Genetics, Department of Obstetrics & Gynecology, Medical College of Georgia at Augusta University, Augusta, GA, USA. Electronic address: sbrakta@augusta.edu.
- Department of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA.
- Section of Reproductive Endocrine, Infertility, & Genetics, Department of Obstetrics & Gynecology, Medical College of Georgia at Augusta University, Augusta, GA, USA.
- University of Pittsburgh, Pittsburgh, PA, USA.
- University of Pennsylvania, Philadelphia, PA, USA.
- Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Förderung
- NICHD
Zitieren
APA
Brakta, S., Du, Q., Chorich, L. P., Hawkins, Z. A., Sullivan, M. E., Ko, E. K., Kim, H. G., Knight, J., Taylor, H. S., Friez, M., Phillips, J. A., & Layman, L. C. (2024). Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Molecular and Cellular Endocrinology, 589, 112237. https://doi.org/10.1016/j.mce.2024.112237
Vancouver
Brakta S, Du Q, Chorich LP, Hawkins ZA, Sullivan ME, Ko EK, et al. Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Molecular and Cellular Endocrinology. 2024;589:112237. doi:10.1016/j.mce.2024.112237
BibTeX
@article{Brakta2024,
author = {Brakta, Soumia and Du, Quansheng and Chorich, Lynn P and Hawkins, Zoe A and Sullivan, Megan E and Ko, Eun Kyung and Kim, Hyung-Goo and Knight, James and Taylor, Hugh S and Friez, Michael and Phillips, John A and Layman, Lawrence C},
title = {Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome},
journal = {Molecular and Cellular Endocrinology},
year = {2024},
volume = {589},
pages = {112237},
doi = {10.1016/j.mce.2024.112237}
}
EUVIMED